Loading...

Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket

Friday, 06 January 2023
Like
Dislike
Share
Report
Edit

OncoCyte Corporation (NASDAQ:OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products that address larger markets. Spruce Biosciences, Inc. (NASDAQ:SPRB) shares rose 84% to $2.30 in pre-market trading. Spruce Biosciences and Kaken Pharmaceutical reported an exclusive licensing agreement to develop and commercialize Tildacerfont for CAH in Japan. CytomX Therapeutics, Inc. (NASDAQ:CTMX) rose 70.4% to $3.